相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Analysis of drug coverage before and after the implementation of Canada's Common Drug Review
John-Michael Gamble et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2011)
Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?
Lesley Chim et al.
PHARMACOECONOMICS (2010)
Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions A Comparison of Britain, Australia, and Canada
Fiona M. Clement et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Drug reimbursement policies in Canada - Need for improved access to critical therapies
Jacques LeLorier et al.
ANNALS OF PHARMACOTHERAPY (2008)
Optimizing the use of prescription drugs in Canada through the Common Drug Review
Mike Tierney et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
The role of value for money in public insurance coverage decisions for drugs in Australia: A retrospective analysis 1994-2004
Anthony H. Harris et al.
MEDICAL DECISION MAKING (2008)
Waiting for reimbursement of new medicines in Canada
Brett J. Skinner
PHARMACOECONOMICS (2008)
The Common Drug Review: A NICE start for Canada?
Meghan McMahon et al.
HEALTH POLICY (2006)
Centralized drug review processes in Australia, Canada, New Zealand, and the United Kingdom
SG Morgan et al.
HEALTH AFFAIRS (2006)
Is the current approach to reviewing new drugs condemning the victims of rare diseases to death? A call for a national orphan drug review policy
JTR Clarke
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Economic evaluations in the Canadian common drug review
Andreas Laupacis
PHARMACOECONOMICS (2006)
Quality, innovation, and value for money - NICE and the British National Health Service
SD Pearson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Adjusting for multiple testing - when and how?
R Bender et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
A dog's breakfast: Prescription drug coverage varies widely across Canada
AH Anis et al.
MEDICAL CARE (2001)
分享论文
